Yong Ben
Director/Board Member at CORBUS PHARMACEUTICALS HOLDINGS, INC.
Net worth: - $ as of 2024-03-30
Profile
Currently, Yong Ben holds the position of Chief Medical Officer-Immuno & Oncology Department at BeiGene Ltd. Dr. Ben received a doctorate from Norman Bethune Medical University and an MBA from the University of California San Diego.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-21 | 0 ( -.--% ) | - $ | 2024-03-30 |
Yong Ben active positions
Companies | Position | Start |
---|---|---|
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 2023-02-28 |
Eight Roads Capital Advisors (CHINA) | Private Equity Investor | - |
Former positions of Yong Ben
Companies | Position | End |
---|---|---|
BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | - |
BIOATLA, INC. | Corporate Officer/Principal | 2019-01-31 |
Training of Yong Ben
University of California San Diego | Masters Business Admin |
Norman Bethune Medical University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
BIOATLA, INC. | Health Technology |
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
BEIGENE, LTD. | Health Technology |
Private companies | 1 |
---|---|
Eight Roads Capital Advisors (CHINA) | Finance |
- Stock Market
- Insiders
- Yong Ben